Rebecca J. Mullan
Mayo Clinic
30 Papers
266 Citations
Rebecca J. Mullan is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 24, co-authored 30 publications. Previous affiliations of Rebecca J. Mullan include University of Rochester & University of Minnesota.
Chat about Author
Papers
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
M. Mercè Fernández-Balsells,Mohammad Hassan Murad,Melanie A. Lane,Juliana F. Lampropulos,Felipe N. Albuquerque,Rebecca J. Mullan,Neera Agrwal,Mohamed B. Elamin,Juan F. Gallegos-Orozco,Amy T. Wang,Patricia J. Erwin,Shalender Bhasin,Victor M. Montori +12 more
TL;DR: The adverse effects of testosterone therapy include an increase in hemoglobin and hematocrit and a small decrease in high-density lipoprotein cholesterol.
710
Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes.
Mohammad Hassan Murad,Mohamed B. Elamin,Magaly Zumaeta Garcia,Rebecca J. Mullan,Ayman Murad,Patricia J. Erwin,Victor M. Montori +6 more
TL;DR: The prognosis of individuals with gender identity disorder (GID) receiving hormonal therapy as a part of sex reassignment in terms of quality of life and other self‐reported psychosocial outcomes is assessed.
591
The Effect of Vitamin D on Falls: A Systematic Review and Meta-Analysis
Mohammad Hassan Murad,Khalid B. Elamin,Nisrin O. Abu Elnour,Mohamed B. Elamin,Aziz A. Alkatib,Mitra M. Fatourechi,Jaime P. Almandoz,Rebecca J. Mullan,Melanie A. Lane,Hau Liu,Patricia J. Erwin,Donald D. Hensrud,Victor M. Montori +12 more
TL;DR: Vitamin D use was associated with statistically significant reduction in the risk of falls and was more prominent in patients who were vitamin D deficient at baseline and in studies in which calcium was coadministered with vitamin D.
Comparative effectiveness of drug treatments to prevent fragility fractures: A systematic review and network meta-analysis
Mohammad Hassan Murad,Matthew T. Drake,Rebecca J. Mullan,Karen F. Mauck,Louise M. Stuart,Melanie A. Lane,Nisrin O. Abu Elnour,Patricia J. Erwin,Ahmad Hazem,Milo A. Puhan,Tianjing Li,Victor M. Montori +11 more
TL;DR: Differences in efficacy across drugs are small; therefore, patients and clinicians need to consider their associated harms and costs.
289
Patient-Important Outcomes in Registered Diabetes Trials
Gunjan Y. Gandhi,M. Hassan Murad,Akira Fujiyoshi,Rebecca J. Mullan,David N. Flynn,Mohamed B. Elamin,Brian A. Swiglo,William L. Isley,Gordon H. Guyatt,Victor M. Montori +9 more
TL;DR: In this sample of registered ongoing RCTs in diabetes, only 18% included patient-important outcomes as primary outcomes, and in multivariate analysis, large trials and type 2 diabetes trials were less likely to assess patient- important outcomes as a primary outcome.
238